Dendritic Branching of Retinal Ganglion Cells as a Biomarker of Glaucomatous Optic Neuropathy and Alzheimer’s Disease and a Target of Neuroprotective Therapy
Irreversible damage to the structure of axons and death of the retinal ganglion cell (RGC) soma in primary open-angle glaucoma (POAG) and Alzheimer’s disease (AD) develop against the background of the already existing clinical manifestation, which is preceded by a slow period of progressive loss of...
Saved in:
| Main Authors: | M. V. Zueva, A. N. Zhuravleva, A. N. Bogolepova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ophthalmology Publishing Group
2021-07-01
|
| Series: | Oftalʹmologiâ |
| Subjects: | |
| Online Access: | https://www.ophthalmojournal.com/opht/article/view/1533 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dendritic Branching of Retinal Ganglion Cells as a Biomarker of Glaucomatous Optic Neuropathy and Alzheimer’s Disease and a Target of Neuroprotective Therapy
by: M. V. Zueva, et al.
Published: (2022-10-01) -
Glaucomatous retinal ganglion cells: death and protection
by: Na Cui, et al.
Published: (2025-01-01) -
Caspase-mediated pathways in retinal ganglion cell injury: a novel therapeutic target for glaucoma
by: Nisha Rajakrishna, et al.
Published: (2025-04-01) -
Electrophysiological markers of preclinical diagnosis of glaucomatous optic neuropathy
by: M. O. Kirillova, et al.
Published: (2021-03-01) -
Hybrid molecule SA-10 and its PLGA nanosuspension protect human and rodent retinal ganglion cells against neuronal injury
by: Jennifer H. Pham, et al.
Published: (2025-08-01)